Genetic Technologies Ltd - American Depositary Shares (GENE)
GENE moved a median of -0.05% 30 minutes after news, and -0.87% by the close. How GENE actually reacts to news — the realized, point-in-time move the market made, measured across 79 labeled events over the last three years with zero look-ahead.
GENE’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 32% | 71 |
| 30-min | -0.05% | 33% | 76 |
| 60-min | -0.96% | 38% | 77 |
| to close | -0.87% | 38% | 79 |
| Middle 50% of GENE reactions | -3.10% to +0.60% |
|---|---|
| Median reaction (30-min) | -0.05% |
| Measured reactions | 79 |
Half of all Genetic Technologies Ltd - American Depositary Shares news events land between -3.10% and +0.60% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when GENE moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to GENE's baseline. Nothing else.
Recent GENE events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on October 2 | Press release | GlobeNewswire | +0.00% | -4.15% | |
| Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform | Press release | GlobeNewswire | -3.12% | +2.12% | |
| Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on August 15 | Press release | GlobeNewswire | +1.08% | +5.16% | |
| Genetic Technologies Strategic Restructure Driving USA Sales Growth | Press release | GlobeNewswire | +4.19% | +8.26% | |
| Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary | Press release | GlobeNewswire | +0.00% | -4.09% | |
| GeneType to Enter Canadian and New Zealand Markets | Press release | GlobeNewswire | — | +1.55% | |
| GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease | Press release | GlobeNewswire | -13.79% | -14.94% | |
| Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27 | Press release | GlobeNewswire | — | +2.41% | |
| Genetic Technologies Expands Operational Capacity in North America | Press release | GlobeNewswire | +2.94% | +1.18% | |
| GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test | Press release | GlobeNewswire | +5.62% | +5.06% | |
| Form 6-K GENETIC TECHNOLOGIES For: May 29 | SEC filing · Form 6-K | SEC EDGAR | -8.33% | -7.35% | |
| GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer | Press release | GlobeNewswire | -8.33% | -7.35% | |
| Form EFFECT GENETIC TECHNOLOGIES | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | +0.47% | |
| GeneType and Humanise Health host “Know Your Risk” Event | Press release | GlobeNewswire | +0.00% | -5.63% | |
| Form F-1 GENETIC TECHNOLOGIES | SEC filing · Form F-1 | SEC EDGAR | +0.00% | -2.56% | |
| Form 6-K GENETIC TECHNOLOGIES For: May 06 | SEC filing · Form 6-K | SEC EDGAR | -5.04% | -4.42% | |
| GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees | Press release | GlobeNewswire | -5.04% | -4.42% | |
| Appendix 4C & Quarterly Business Update – March 2024 | Press release | GlobeNewswire | — | +0.43% | |
| Form 6-K GENETIC TECHNOLOGIES For: Apr 30 | SEC filing · Form 6-K | SEC EDGAR | — | +0.43% | |
| Form 6-K GENETIC TECHNOLOGIES For: Apr 23 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -0.83% | |
| Form 6-K GENETIC TECHNOLOGIES For: Apr 22 | SEC filing · Form 6-K | SEC EDGAR | +5.37% | +3.49% | |
| Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering | Press release | GlobeNewswire | — | +0.00% | |
| Form 6-K GENETIC TECHNOLOGIES For: Apr 19 | SEC filing · Form 6-K | SEC EDGAR | -1.25% | -3.33% | |
| Genetic Technologies Announces $2 Million Registered Direct Offering | Press release | GlobeNewswire | -14.65% | -12.86% | |
| Form 6-K GENETIC TECHNOLOGIES For: Apr 17 | SEC filing · Form 6-K | SEC EDGAR | -2.44% | -3.66% | |
| New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes | Press release | GlobeNewswire | -2.44% | -3.66% | |
| GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year | Press release | GlobeNewswire | -2.14% | -3.06% | |
| Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV | Press release | Accesswire | +0.00% | -0.87% | |
| Form 6-K GENETIC TECHNOLOGIES For: Apr 11 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +4.92% | |
| GTG to pilot GeneType in Breast Screen centers across the U.S. | Press release | GlobeNewswire | +0.00% | +4.92% | |
| EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk” | Press release | GlobeNewswire | +0.00% | -1.74% | |
| Form 6-K GENETIC TECHNOLOGIES For: Apr 08 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -1.74% | |
| Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market | Press release | GlobeNewswire | -4.41% | -8.14% | |
| Form 6-K GENETIC TECHNOLOGIES For: Mar 26 | SEC filing · Form 6-K | SEC EDGAR | +0.79% | +7.12% | |
| GTG Global Collaborations and Innovation Update | Press release | GlobeNewswire | +0.79% | +7.12% | |
| Form 6-K GENETIC TECHNOLOGIES For: Mar 25 | SEC filing · Form 6-K | SEC EDGAR | +0.37% | -5.18% | |
| GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare | Press release | GlobeNewswire | +0.37% | -5.18% | |
| Form 6-K GENETIC TECHNOLOGIES For: Mar 20 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +4.71% | |
| Form 6-K GENETIC TECHNOLOGIES For: Mar 20 | SEC filing · Form 6-K | SEC EDGAR | -1.59% | -8.09% | |
| Form 6-K GENETIC TECHNOLOGIES For: Mar 06 | SEC filing · Form 6-K | SEC EDGAR | -1.36% | -5.78% | |
| GTG to launch U.S. Customer Digital Media Sales Campaign | Press release | GlobeNewswire | +0.48% | -6.19% | |
| Form 6-K GENETIC TECHNOLOGIES For: Dec 31 | SEC filing · Form 6-K | SEC EDGAR | -0.51% | -3.06% | |
| Form 6-K GENETIC TECHNOLOGIES For: Feb 20 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -6.22% | |
| Form 6-K GENETIC TECHNOLOGIES For: Feb 15 | SEC filing · Form 6-K | SEC EDGAR | — | +3.23% | |
| Form 6-K GENETIC TECHNOLOGIES For: Feb 07 | SEC filing · Form 6-K | SEC EDGAR | +3.14% | +0.52% | |
| Form 6-K GENETIC TECHNOLOGIES For: Jan 31 | SEC filing · Form 6-K | SEC EDGAR | -0.36% | -6.70% | |
| Launching our most comprehensive test and expanding into new global markets | Press release | GlobeNewswire | -0.36% | -6.70% | |
| Form 6-K GENETIC TECHNOLOGIES For: Jan 09 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -0.38% | |
| Form 6-K GENETIC TECHNOLOGIES For: Jan 05 | SEC filing · Form 6-K | SEC EDGAR | -0.02% | -3.31% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the GENE section they belong to.
Where else GENE is measured.
GENE earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Orchard Therapeutics plc - American Depositary Shares (ORTX) | 80 | +0.06% | 66% |
| Elite Pharmaceuticals, Inc. (ELTP) | 79 | -0.11% | 42% |
| MOTIF BIO PLC ADRS (MTFB) | 79 | 0.00% | 39% |
| Affimed N.V. (AFMD) | 78 | -2.06% | 27% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Genetic Technologies Ltd - American Depositary Shares's median reaction calculated?
Every labeled GENE news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 79 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 33% of GENE's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does GENE's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.